
Sign up to save your podcasts
Or


BP Lowering in CKD: Consistent. Comprehensive. Compelling. 📉🫀
A landmark individual-participant meta-analysis (285K+ patients) shows that every 5 mm Hg reduction in systolic BP reduces major cardiovascular events by ~10%—across all CKD stages.
Key insight: the benefit holds even at lower BP levels and across drug classes. ⚖️ But in CKD + diabetes, the effect attenuates—reminding us that biology resists simplicity. đź§
The message is clear: BP control remains one of the most powerful, scalable tools in CKD care.
Precision is next. Implementation is everything. 🚀
By Dr RR Baliga, MD, MBA5
66 ratings
BP Lowering in CKD: Consistent. Comprehensive. Compelling. 📉🫀
A landmark individual-participant meta-analysis (285K+ patients) shows that every 5 mm Hg reduction in systolic BP reduces major cardiovascular events by ~10%—across all CKD stages.
Key insight: the benefit holds even at lower BP levels and across drug classes. ⚖️ But in CKD + diabetes, the effect attenuates—reminding us that biology resists simplicity. đź§
The message is clear: BP control remains one of the most powerful, scalable tools in CKD care.
Precision is next. Implementation is everything. 🚀

906 Listeners

3,374 Listeners

20,222 Listeners